Regarding the three newly identified miRNA candidates, as of now miR-127-3p has been described as up-regulated in a subtype of acute myeloid leukemia and colorectal cancer with KRAS mutations and decreased in osteosarcoma cell lines and in primary breast cancer tissue [28]–[31]. Here, KRAS is linked to osteosarcoma.